The European Union’s Good Manufacturing Practices (GMP) standard is a regulatory requirement that helps ensure cannabis product safety. All cannabis products produced domestically or imported to the European Union must be GMP-compliant before being sold in EU markets.

Legal medical cannabis producers, product makers, and other members of the international industry are trying harder than ever to gain a foothold in Europe’s emerging medical cannabis market, and one of the foundational starting points for every expansion plan is a sufficient understanding of GMP compliance, with science-based decontamination processes being at the heart of European GMP cannabis compliance.

A team of expert panelists discussed various approaches to cannabis decontamination, the regulatory requirements involved, and the unique GMP compliance hurdles that cannabis companies can expect at the recent International Cannabis Conference in Berlin. The panel was moderated by Constant Ma, CEO and President of Cannactions Consulting Ltd. Other panelists included:

• George Terry – Executive Vice President, Rad Source
• Joseph Edwards – Chief Scientist and Vice President, Deconix
• Matthieu van der Born – CEO and Founder, Flower Power
• Rui Soares – Founder And CEO, Paralab
• Ed Wells – Vice President of Sales, Cannatrol

You can view the panel discussion in its entirety at this link here.